Jay R. Venkatesan
2022
In 2022, Jay R. Venkatesan earned a total compensation of $1.5M as former Chief Executive Officer, President, and Chairman of the Angion Board at Elicio Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $11,876 |
|---|---|
| Option Awards | $898,973 |
| Salary | $608,000 |
| Total | $1,518,849 |
Venkatesan received $899K in option awards, accounting for 59% of the total pay in 2022.
Venkatesan also received $11.9K in non-equity incentive plan and $608K in salary.
Rankings
In 2022, Jay R. Venkatesan's compensation ranked 2,204th out of 5,756 executives tracked by ExecPay. In other words, Venkatesan earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,204 out of 5,756 | 62nd |
Division Manufacturing | 1,189 out of 3,133 | 62nd |
Major group Chemicals And Allied Products | 512 out of 1,419 | 64th |
Industry group Drugs | 472 out of 1,320 | 64th |
Industry Pharmaceutical Preparations | 344 out of 966 | 64th |
Source: SEC filing on September 27, 2024.
Venkatesan's colleagues
We found three more compensation records of executives who worked with Jay R. Venkatesan at Elicio Therapeutics in 2022.